Sign in
4

Changes in Ownership

PLIANT THERAPEUTICS, INC. Filed Acc 0001140361-23-000721

President and CEO sold 30,000 shares at an average $19.20 ($575,892)

  • President and CEO acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Coulie Bernard · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-03 Exercise or conversion : show line 1 in the form +15,000 $2.08 $31,200 108,812 D
2023-01-03 Sale : show line 2 in the form −15,000 $19.33 $289,952 93,812 D
2023-01-04 Exercise or conversion : show line 3 in the form +15,000 $2.08 $31,200 108,812 D
2023-01-04 Sale : show line 4 in the form −15,000 $19.06 $285,941 93,812 D
Open-market sales · 30,000 sh · avg $19.20 · $575,892

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-01-03 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −15,000 282,380 D
2023-01-04 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −15,000 267,380 D
Loading xslF345X03/form4.xml…